Gilead Sciences · 1 day ago
Director, US HIV Prevention (PrEP) Forecasting
Gilead Sciences is committed to creating a healthier world by developing therapies for life-threatening illnesses. As the Director of US HIV Prevention (PrEP) Forecasting, you will lead demand forecasting for Gilead’s US HIV PrEP portfolio and collaborate with various stakeholders to drive business success.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Responsible for demand forecasting across brands in the US HIV PrEP business (including daily and long-acting oral(s) and long acting injectable(s)) as well as monthly Actual vs Forecast (AvF) reporting
Lead and deliver Gilead’s quarterly Latest Estimate (LE) forecasting for US HIV PrEP, including developing forecast scenario analyses, highlighting key risks and opportunities to characterize forecast uncertainties and critical drivers for executive leadership
Developing forecast scenario analyses, including key risks and opportunities, to characterize forecast uncertainties and key drivers for executive leadership
Support the preparation of the quarterly CCO Binder and earnings deliverables for HIV PrEP with the Executive Director
Analyze secondary data sources (script data like IQVIA, audit data like Ipsos, epidemiology data like NHANES, claims data, etc.) to glean insights and understand implications for our business, inform our strategies, and make actionable recommendations
Collaborate within HIV Integrated Insights on key forecast inputs, including market research commercial analytics, and with cross-functional partners, including US sales analytics/field-force assumptions and our Global forecasting and analytics colleagues
Regularly communicate with senior executives and strategic partners to report analytical findings and projections related to forecasting, inventory management, and essential performance metrics/diagnostics
Lead performance reporting and diagnostics, including design and implementation of HQ facing dashboards and reports
Seek and implement opportunities to streamline and improve business operations and technical capabilities of the organization while identifying opportunities to drive forecasting innovation and performance
Qualification
Required
Bachelor's Degree and Twelve Years' Experience
OR
Masters' Degree and Ten Years' Experience
OR
PhD and Eight Years' Experience
Responsible for demand forecasting across brands in the US HIV PrEP business (including daily and long-acting oral(s) and long acting injectable(s)) as well as monthly Actual vs Forecast (AvF) reporting
Lead and deliver Gilead's quarterly Latest Estimate (LE) forecasting for US HIV PrEP, including developing forecast scenario analyses, highlighting key risks and opportunities to characterize forecast uncertainties and critical drivers for executive leadership
Developing forecast scenario analyses, including key risks and opportunities, to characterize forecast uncertainties and key drivers for executive leadership
Support the preparation of the quarterly CCO Binder and earnings deliverables for HIV PrEP with the Executive Director
Analyze secondary data sources (script data like IQVIA, audit data like Ipsos, epidemiology data like NHANES, claims data, etc.) to glean insights and understand implications for our business, inform our strategies, and make actionable recommendations
Collaborate within HIV Integrated Insights on key forecast inputs, including market research commercial analytics, and with cross-functional partners, including US sales analytics/field-force assumptions and our Global forecasting and analytics colleagues
Regularly communicate with senior executives and strategic partners to report analytical findings and projections related to forecasting, inventory management, and essential performance metrics/diagnostics
Lead performance reporting and diagnostics, including design and implementation of HQ facing dashboards and reports
Seek and implement opportunities to streamline and improve business operations and technical capabilities of the organization while identifying opportunities to drive forecasting innovation and performance
Preferred
Minimum of 12 years' experience in Pharmaceutical, Biotech, or related industry experience, dependent on experience and education level. BS degree (or higher) in life sciences or medicine (or equivalent); Advanced degrees desirable
Strong prior experience in biotech/pharma demand / revenue forecasting is required, and a foundation of experience in HIV or virology therapy areas is desired
Demonstrated ability to influence without formal authority brings clarity in ambiguous situations and remains calm under pressure
Persuasive written and verbal communication skills, ability to lead, influence, resolve conflict, and drive consensus among diverse cross-functional stakeholders
Proven experience in storytelling and data visualization to communicate complicated analytics clearly for senior management/Deep understanding of biotech/pharma market trends and best practices to enable forward-looking plans
Proven history of working and delivering on multiple projects simultaneously, with tight deadlines and changing priorities
Strong ability to use Microsoft Office (specifically PowerPoint and Excel) to present quantitative data in graphical form
Evidence of project leadership and project management (planning, prioritization, objective setting, meeting management, and plan execution) is essential
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2026-01-09
2026-01-08
2026-01-07
Company data provided by crunchbase